Rong X, Li X, Gou Q, Liu K, Chen X
For patients experiencing mid-week appetite return or variable tolerance, compounded GLP-1 formulations (semaglutide or tirzepatide) offer flexibility in dosing, concentration, and delivery route
If approved, Pfizers drug candidate will be a once-monthly GLP-1 injection, compared to weekly injections needed with todays top GLP-1 sellers by Lilly and Novo Nordisk
In addition, the presence of 4-hydroxyproline in the GlyXY collagen peptides reduces chemotaxis and blocks apoptosis in neutrophils, while the hydroxylation of two proline residues in hypoxia-inducible factor- to form 4-hydroxyproline under normoxic oxygen conditions triggers the proteasomal degradation of the protein to regulate its abundance (Wu et al
(See "Ozempic Is Costing Grocery Stores Billions" and "Ozempic Is Shrinking Appetites